Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03651076 · ClinicalTrials.gov registry record · NA
Traxi Panniculus Retractor for Cesarean Delivery
A NA study, sponsored by Beth Israel Deaconess Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 142
- Enrollment target
NCT03651076 is a NA study that was terminated before completion, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 142 participants.
The verdict
NCT03651076, a NA study, was terminated before completion, sponsored by Beth Israel Deaconess Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 142 participants
- Enrollment target
Study Summary
This prospective, open-label, randomized-controlled trial is designed to evaluate the use of the Traxi panniculus retractor-- a commercially available Class I FDA-exempt device will improve surgical outcomes, cardiopulmonary function, and provider/patient satisfaction in morbidly obese women undergoing cesarean delivery.
Interventions
- DEVICE Traxi panniculus retraction (Clinical Innovations, LLC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 142 participants |
| Start Date | 2018-10-02 |
| Est. Completion | 2025-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03651076
The ClinicalTrials.gov registry entry for NCT03651076 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 142 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Traxi panniculus retraction (Clinical Innovations, LLC) is the first listed.
NCT03651076 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03651076 about?
NCT03651076 is a clinical study titled "Traxi Panniculus Retractor for Cesarean Delivery". This prospective, open-label, randomized-controlled trial is designed to evaluate the use of the Traxi panniculus retractor-- a commercially available Class I FDA-exempt device will improve surgical outcomes, cardiopulmonary function, and provider/patient satisfaction in morbidly obese women undergo...
What is the current status of trial NCT03651076?
This trial is currently terminated. It is a NA study. The enrollment target is 142 participants. The study started on 2018-10-02. Estimated completion is 2025-02-01.
What interventions are being tested in trial NCT03651076?
The interventions under investigation include: Traxi panniculus retraction (Clinical Innovations, LLC) (DEVICE).
Who is sponsoring clinical trial NCT03651076?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.